IMAX vs RGC

IMAX Corporation (IMAX) offers the better valuation at 56.

7x trailing P/E (21. 2x forward), making it the more compelling value choice. Analysts rate IMAX Corporation (IMAX) a "Buy" — based on 25 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Regencell Bioscience Holdings Limited (RGC) delivered a total return of +98.

9%, compared to +76. 6% for IMAX Corporation (IMAX). Over 10 years, the gap is even starker: RGC returned +105. 2% versus IMAX's +8. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), IMAX Corporation (IMAX) is the lower-risk stock at 0.

43β versus Regencell Bioscience Holdings Limited's 0. 72β — meaning RGC is approximately 69% more volatile than IMAX relative to the S&P 500. On balance sheet safety, Regencell Bioscience Holdings Limited (RGC) carries a lower debt/equity ratio of 1% versus 70% for IMAX Corporation — giving it more financial flexibility in a downturn.

On earnings-per-share growth, the picture is similar: IMAX Corporation grew EPS 31.

3% year-over-year, compared to 26. 9% for Regencell Bioscience Holdings Limited. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

IMAX Corporation (IMAX) is the more profitable company, earning 8.

5% net margin versus 0. 0% for Regencell Bioscience Holdings Limited — meaning it keeps 8. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: IMAX leads at 23. 3% versus 0. 0% for RGC. At the gross margin level — before operating expenses — IMAX leads at 57. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, IMAX Corporation (IMAX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

43)). Both have compounded well over 10 years (IMAX: +8. 5%, RGC: +105. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (IMAX (Communication Services) and RGC (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: IMAX is a small-cap high-growth stock; RGC is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.